Erythrocyte-bound interleukin-8 and RANTES in human endotoxemia

Journal of Endotoxin Research

Volumn 4, Issue 1, 1997, Pages 1-7

  Manten, A ^a   Pajkrt, D ^a   De Winter, R J ^a   De Jong, Y P ^a   Jansen, J ^a   Ten Cate, J W ^a   Van Deventer, S J ^a  

^a ACADEMIC MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ENDOTOXIN; INTERLEUKIN 8; RANTES;

ADULT; ARTICLE; BLOOD LEVEL; ENDOTOXEMIA; ERYTHROCYTE; HUMAN; HUMAN CELL; HUMAN EXPERIMENT; MALE; NORMAL HUMAN;

EID: 0030917512     PISSN: 09680519     EISSN: None     Source Type: Journal    
DOI: 10.1177/096805199700400101     Document Type: Article

References (47)

1. Rot A. Endothelial cell binding of NAP-1/IL-8: role in neutrophil emigration. Immunol Today 1992; 13: 291-294.
2. Huber A.R., Kunkel S.L., Todd I., Weiss S.J. Regulation of transendothelial neutrophil migration by endogenous interleukin-8. Science 1991; 254: 99-102.
3. Miller M.D., Krangel M.S. Biology and biochemistry of the chemokines: a family of chemotactic and inflammatory cytokines. Crit Rev Immunol 1992; 12: 17-46.
4. Baggiolini M., Dewald B., Moser B. Interleukin-8 and related cytokines-CXC and CC chemokines. Adv Immunol 1994; 55: 97-179.
5. Baggiolini M., Clark-Lewis I. Interleukin-8, a chemotactic and inflammatory cytokine. FEBS Lett 1992; 307: 97-101.
6. Yoshimura T., Matshushima K., Oppenheim J.J., Leonard E.J. Neutrophil chemotactic factor produced by lipopolysaccharide (LPS)-stimulated human mononuclear leukocytes: partial characterization and separation from interleukin 1 (IL 1). J Immunol 1987; 139: 788-793.
7. Matshushima K., Morishita K., Yoshimura T. et al. Molecular cloning of a human monocyte-derived neutrophil chemotactic factor (MDNCF) and the induction of MDNCF mRNA by interleukin 1 and tumor necrosis factor. J Exp Med 1988; 167: 1883-1893.
8. Baggiolini M., Imboden P., Detmers P. Neutrophil activation and the effects of interleukin-8/neutrophil-activating peptide 1 (IL-8/NAP-1). In: Baggiolini M., Sorg C. Eds Cytokines. Basel: Karger, 1992; 1-17.
9. van Zee K.J., Fischer E., Hawes A.S. et al. Effects of intravenous IL-8 administration in nonhuman primates. J Immunol 1992; 148: 1746-1752.
10. Hechtman D.H., Cybulsky M.I., Fuchs H.J., Baker J.B., Gimbrone M.A. Intravascular IL-8. Inhibitor of polymorphonuclear leukocyte accumulation at sites of acute inflammation. J Immunol 1991; 147: 883-892.
11. Gimbrone M.A., Obin M.S., Brock A.F. et al. Endothelial interleukin-8: a novel inhibitor of leukocyte-endothelial interactions. Science 1989; 246: 1601-1603.
12. Luscinskas F.W., Kiely J., Ding H. et al. In vitro inhibitory effect of IL-8 and other chemoattractants on neutrophil-endothelial adhesive interactions. J Immunol 1992; 149: 2163-2171.
13. Ley K., Baker J.B., Cybulski M.I., Gimbrone M.A., Luscinskas F.W. Intravenous interleukin-8 inhibits granulocyte emigration from rabbit mesenteric venules without altering L-selectin expression or leukocyte rolling. J Immunol 1993; 151: 6347-6357.
14. Simonet W.S., Hughes T.M., Nguyen H.Q., Trebasky L.D., Danilenko D.M. Long-term impaired neutrophil migration in mice overexpressing human interleukin-8. J Clin Invest 1994; 94: 1310-1319.
15. Schall T.J., Jongstra J., Dyer B.J. et al. A human T cell-specific molecule is a member of a new gene family. J Immunol 1988; 141: 1018-1025.
16. Marfaing-Koka A., Devergne O., Gorgone G. et al. Regulation of the production of the RANTES chemokine by endothelial cells. J Immunol 1995; 154: 1870-1878.
17. Kameyoshi Y., Dörschner A., Mallet A.I., Christophers E., Schröder J. Cytokine RANTES released by thrombin-stimulated platelets is a potent attractant for human eosinophils. J Exp Med 1992; 176: 587-592.
18. Uguccioni M., D'Apuzzo M., Loetscher M., Dewald B., Baggiolini M. Actions of the chemotactic cytokines MCP-1, MCP-2, MCP-3, RANTES, MIP-1a and MIP-1b on human monocytes. Eur J Immunol 1995; 25: 64-68.
19. Schall T.J., Bacon K., Toy K.J., Goeddel D.V. Selective attraction of monocytes and T lymphocytes of the memory phenotype by cytokine RANTES. Nature 1990; 347: 669-671.
20. Bischoff S.C., Krieger M, Brunner T. et al. RANTES and related chemokines activate human basophil granulocytes through different G protein-coupled receptors. Eur J Immunol 1993; 23: 761-767.
21. Rot A., Krieger M, Brunner T., Bischoff S.C., Schall T.J., Dahinden C.A. RANTES and macrophage inflammatory protein 1a induce the migration and activation of normal human eosinophil granulocytes. J Exp Med 1992; 176: 1489-1495.
22. Mattoli S., Ackerman V., Vittori E., Marini M. Mast cell chemotactic activity of RANTES. Biochem Biophys Res Commun 1995; 209: 316-321.
23. Strieter R.M., Koch A.E., Antony V.B., Fick R.B., Standiford T.J., Kunkel S.L. The immunopathology of chemotactic cytokines: the role of interleukin-8 and monocyte chemotactic protein-1. J Lab Clin Med 1994; 123: 183-197.
24. Furie M.B., Randolph G.J. Chemokines and tissue injury. Am J Pathol 1995; 146: 1287-1301.
25. Friedland J.S. Chemokines and human infection. Clin Sci 1995; 88: 393-400.
26. Rathanaswami P., Hachicha M., Sadick M., Schall T.J., McColl S.R. Expression of the cytokine RANTES in human rheumatoid synovial fibroblasts. J Biol Chem 1995; 268: 5834-5839.
27. Schwartz C.J., Valente A.J., Sprague E.A. A modern view of atherogenesis. Am J Cardiol 1993; 71: 9B-14B.
28. n in a rabbit model of myocardial ischemia and reperfusion. Br J Pharmacol 1991; 103: 1153-1159.
29. Ivey C.L., Williams F.M., Coffins P.D., Jose P.J., Williams T.J. Neutrophil chemoattractants generated in two phases during reperfusion of ischemic myocardium in the rabbit. J Clin Invest 1995; 95: 2720-2728.
30. Kukielka G.L., Wayne Smith C., LaRosa G.J. et al. Interleukin-8 gene induction in the myocardium after ischemia and reperfusion in vivo. J Clin Invest 1995; 95: 89-103.
31. Sekido N., Mukalda N., Harada A., Nakanishi I., Watanabe Y., Matshushima K. Prevention of lung reperfusion injury by a monoclonal antibody against interleukin-8. Nature 1993; 365: 654-657.
32. Horuk R., Colby T.J., Darbonne W.C., Schall T.J., Neote K. The human erythrocyte inflammatory peptide (chemokine) receptor. Biochemical characterization, solubilization, and development of a binding assay for the soluble receptor. Biochemistry 1993; 32: 5733-5738.
33. Neote K., Darbonne W.C., Ogez J., Horuk R., Schall T.J. Identification of a promiscuous inflammatory peptide receptor on the surface of red blood cells. J Biol Chem 1993; 268: 12247-12249.
34. Neote K., Mak J.Y., Kolakowski L.F., Schall T.J. Functional and biochemical analysis of the cloned Duffy antigen: identity with the red blood cell chemokine receptor. Blood 1994; 84: 44-52.
35. Horuk R. The interleukin-8-receptor family: from chemokines to malaria. Immunol Today 1994; 15: 169-174.
36. Horuk R., Chitnis C.E., Darbonne W.C. et al. A receptor for the malarial parasite Plasmodium vivax: the erythrocyte chemokine receptor. Science 1995; 261: 1182-261.
37. Chaudhuri A., Zbrzezna V., Polyakova J., Pogo A.O., Hesselgesser J., Horuk R. Expression of the Duffy antigen in K562 cells. J Biol Chem 1994; 269: 7835-7838.
38. Darbonne W.C., Rice G.C., Mohler M.A., Hébert C.A., Valente A.J., Baker J.B. Red blood cells are a sink for interleukin 8, a leukocyte chemotaxin. J Clin Invest 1991; 88: 1362-1369.
39. Tilg H., Pape D., Trehu E. et al. A method for the detection of erythrocyte-bound interIeukin-8 in humans during interleukin-1 immunotherapy. J Immunol Methods 1993; 163: 253-258.
40. Tilg H., Shapiro L, Atkins M.B., Dinarello C.A., Mier J.W. Induction of circulating and erythrocyte-bound IL-8 by IL-2 immunotherapy and suppression of its in vitro production by IL-1 receptor antagonist and soluble tumor necrosis factor receptor (p75) chimera. J Immunol 1993; 151: 3299-3307.
41. 23). J Infect Dis 1995; 172: 144-151.
42. Kooyman D.L., Byrne G.W., McClellan S. et al. In vivo transfer of GPI-linked complement restriction factors from erythrocytes to the endothelium. Science 1995; 269: 89-92.
43. VanOtteren G.M., Strieter R.M., Kunkel S.L. et al. Compartmentalized expression of RANTES in a murine model of endotoxemia. J Immunol 1995; 154: 1900-1908.
44. Hadley T.J., Lu Z., Wasniowska K. et al. Postcapilliary venule endothelial cells in kidney express a multispecific chemokine receptor that is structurally and functionally identical to the erythroid isoform, which is the Duffy blood group antigen. J Clin Invest 1994; 94: 985-991.
45. Ahuja S.K., Gao J., Murphy P.M. Chemokine receptors and molecular mimicry. Immunol Today 1994; 15: 281-287.
46. Murphy P.M. The molecular biology of leukocyte chemoattractant receptors. Annu Rev Immunol 1994; 12: 953-633.
47. Peiper S.C., Wang Z., Neote K. et al. The Duffy antigen/receptor for chemokines (DARC) is expressed in endothelial cells of Duffy negative individuals who lack the erythrocyte receptor. J Exp Med 1995; 181: 1311-1317.